DCF — ST. CLAIRE MEDICAL CENTER
Enterprise Value: $-281.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-281.9M
Enterprise Value
$-90.3M
PV of Cash Flows
$-191.6M
PV of Terminal Value
$-308.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $210.6M | $-16.9M | -8.0% | $-25.9M | $-23.5M |
| Year 2 | $216.9M | $-15.3M | -7.0% | $-24.5M | $-20.2M |
| Year 3 | $223.4M | $-13.5M | -6.0% | $-23.0M | $-17.2M |
| Year 4 | $230.2M | $-12.8M | -6.0% | $-22.5M | $-15.4M |
| Year 5 | $237.1M | $-12.5M | -5.0% | $-22.6M | $-14.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-281.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$204.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.08540562366610646
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5